NO180167C - Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol - Google Patents
Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosolInfo
- Publication number
- NO180167C NO180167C NO943327A NO943327A NO180167C NO 180167 C NO180167 C NO 180167C NO 943327 A NO943327 A NO 943327A NO 943327 A NO943327 A NO 943327A NO 180167 C NO180167 C NO 180167C
- Authority
- NO
- Norway
- Prior art keywords
- cells
- cytosol
- introducing molecules
- photochemical method
- photodynamic treatment
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 210000000172 cytosol Anatomy 0.000 title 1
- 238000002428 photodynamic therapy Methods 0.000 abstract 2
- 210000001163 endosome Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000002132 lysosomal effect Effects 0.000 abstract 1
- 210000003712 lysosome Anatomy 0.000 abstract 1
- 230000001868 lysosomic effect Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Catalysts (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (24)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO943327A NO180167C (no) | 1994-09-08 | 1994-09-08 | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| AU35347/95A AU700797B2 (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells |
| HK98103468.0A HK1004110B (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells |
| CA2199290A CA2199290C (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells |
| PT95932244T PT783323E (pt) | 1994-09-08 | 1995-09-04 | Transferencia de moleculas para o citosol de celulas por meio de compostos fotossensibilizantes |
| PCT/NO1995/000149 WO1996007432A1 (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells |
| ES95932244T ES2163527T3 (es) | 1994-09-08 | 1995-09-04 | Transferencia de moleculas hacia el interior del citosol de las celulas por medio de sustancias fotosensibilizadoras. |
| DE69524238T DE69524238T2 (de) | 1994-09-08 | 1995-09-04 | Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen |
| NZ293008A NZ293008A (en) | 1994-09-08 | 1995-09-04 | Photoactivatable compound-carrier molecule conjugates for transfer into a cell cytosol where they are taken up by endosomes and lysosomes |
| US08/793,794 US5876989A (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells |
| AT95932244T ATE209507T1 (de) | 1994-09-08 | 1995-09-04 | Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen |
| JP50940496A JP4148328B2 (ja) | 1994-09-08 | 1995-09-04 | 細胞サイトゾルへの化合物の移入 |
| EP95932244A EP0783323B1 (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells by photosensitizing compounds |
| NZ509519A NZ509519A (en) | 1994-09-08 | 1995-09-04 | Transfer of molecules into the cytosol of cells |
| CZ97658A CZ65897A3 (en) | 1994-09-08 | 1995-09-04 | Method of transferring molecules into cytosol of cells, set for making the method and a mixture for modification neoplastic or other cellular processes |
| HU9800153A HU222984B1 (hu) | 1994-09-08 | 1995-09-04 | Eljárás molekulák in vitro bevezetésére élő sejtek citoszoljába, fotoszenzibilizáló vegyület alkalmazásával |
| CNB951960652A CN1222309C (zh) | 1994-09-08 | 1995-09-04 | 将分子导入细胞溶质 |
| MX9701676A MX9701676A (es) | 1994-09-08 | 1995-09-04 | Transferencia de moleculas al citosol de celulas. |
| BRPI9508825A BRPI9508825B8 (pt) | 1994-09-08 | 1995-09-04 | processo de transferência de moléculas para o citosol de células, composição e kit |
| KR10-2003-7005142A KR100529967B1 (ko) | 1994-09-08 | 1995-09-14 | 세포의 시토졸내로 분자를 전달시키는 조성물 |
| KR1019970701520A KR100395615B1 (ko) | 1994-09-08 | 1995-09-14 | 세포의시토졸내로분자를전달시키는방법 |
| FI970983A FI121328B (fi) | 1994-09-08 | 1997-03-07 | Molekyylien siirto solujen sytosoliin |
| US09/144,750 US6680301B2 (en) | 1994-09-08 | 1998-09-01 | Transfer of molecules into the cytosol of cells |
| US10/286,632 US20030134813A1 (en) | 1994-09-08 | 2002-11-01 | Transfer of molecules into the cytosol of cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO943327A NO180167C (no) | 1994-09-08 | 1994-09-08 | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO943327D0 NO943327D0 (no) | 1994-09-08 |
| NO943327L NO943327L (no) | 1996-03-11 |
| NO180167B NO180167B (no) | 1996-11-18 |
| NO180167C true NO180167C (no) | 1997-02-26 |
Family
ID=19897382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO943327A NO180167C (no) | 1994-09-08 | 1994-09-08 | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US5876989A (cs) |
| EP (1) | EP0783323B1 (cs) |
| JP (1) | JP4148328B2 (cs) |
| KR (2) | KR100529967B1 (cs) |
| CN (1) | CN1222309C (cs) |
| AT (1) | ATE209507T1 (cs) |
| AU (1) | AU700797B2 (cs) |
| BR (1) | BRPI9508825B8 (cs) |
| CA (1) | CA2199290C (cs) |
| CZ (1) | CZ65897A3 (cs) |
| DE (1) | DE69524238T2 (cs) |
| ES (1) | ES2163527T3 (cs) |
| FI (1) | FI121328B (cs) |
| HU (1) | HU222984B1 (cs) |
| MX (1) | MX9701676A (cs) |
| NO (1) | NO180167C (cs) |
| NZ (2) | NZ509519A (cs) |
| PT (1) | PT783323E (cs) |
| WO (1) | WO1996007432A1 (cs) |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO180167C (no) * | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US6210356B1 (en) * | 1998-08-05 | 2001-04-03 | Ekos Corporation | Ultrasound assembly for use with a catheter |
| US6176842B1 (en) * | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
| US5995867A (en) * | 1997-03-19 | 1999-11-30 | Lucid Inc | Cellular surgery utilizing confocal microscopy |
| US6582392B1 (en) | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
| US6676626B1 (en) | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
| ES2356342T3 (es) * | 1998-01-05 | 2011-04-07 | The University Of Washington | Mejora de transporte utilizando agentes de alteración de membrana. |
| US6399769B1 (en) * | 1998-01-20 | 2002-06-04 | Kimberly-Clark Worldwide, Inc. | Method of making sulfanatophenyl substituted porphines |
| GB9905911D0 (en) * | 1999-03-15 | 1999-05-05 | Photocure As | Method |
| WO2001019953A1 (en) * | 1999-09-09 | 2001-03-22 | Center For Advanced Science And Technology Incubation, Ltd. | Method of piercing membrane and apparatus therefor |
| US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| DK1301213T3 (en) * | 2000-07-21 | 2017-03-27 | Revance Therapeutics Inc | MULTI-COMPONENT SYSTEMS FOR BIOLOGICAL TRANSPORT |
| EP1346059B1 (en) * | 2000-11-29 | 2012-05-23 | PCI Biotech AS | Photochemical internalization for delivery of molecules into the cytosol |
| AU2210402A (en) | 2000-11-29 | 2002-06-11 | Norwegian Radium Hospital Res | Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| US20020098472A1 (en) * | 2000-11-30 | 2002-07-25 | Erlach Julian Van | Method for inserting a microdevice or a nanodevice into a body fluid stream |
| US20020137901A1 (en) * | 2001-01-22 | 2002-09-26 | Cavanaugh Philip Gerard | Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin |
| AU2002250034A1 (en) * | 2001-02-08 | 2002-08-19 | Sequitur, Inc. | Methods of light activated release 0f ligands from endosomes |
| ATE429930T1 (de) * | 2001-06-20 | 2009-05-15 | Dainippon Sumitomo Pharma Co | Verfahren zur förderung des nukleinsäuretransfers |
| GB0121023D0 (en) * | 2001-08-30 | 2001-10-24 | Norwegian Radium Hospital Res | Compound |
| US7220239B2 (en) | 2001-12-03 | 2007-05-22 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
| US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
| US20030166282A1 (en) * | 2002-02-01 | 2003-09-04 | David Brown | High potency siRNAS for reducing the expression of target genes |
| EP1478656B1 (en) * | 2002-02-01 | 2009-09-16 | Life Technologies Corporation | Oligonucleotide compositions with enhanced efficiency |
| US20060009409A1 (en) | 2002-02-01 | 2006-01-12 | Woolf Tod M | Double-stranded oligonucleotides |
| US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
| US20040248094A1 (en) * | 2002-06-12 | 2004-12-09 | Ford Lance P. | Methods and compositions relating to labeled RNA molecules that reduce gene expression |
| GB0215534D0 (en) * | 2002-07-04 | 2002-08-14 | Ecole Polytech | Selective photochemotherapy using oligonucleotide targeting agents |
| US20040029275A1 (en) * | 2002-08-10 | 2004-02-12 | David Brown | Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs |
| US6921371B2 (en) * | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
| CA2513072A1 (en) * | 2003-01-09 | 2004-07-29 | Invitrogen Corporation | Cellular delivery and activation polypeptide-nucleic acid complexes |
| US7332477B2 (en) * | 2003-07-10 | 2008-02-19 | Nitto Denko Corporation | Photocleavable DNA transfer agent |
| WO2005032597A1 (en) * | 2003-09-29 | 2005-04-14 | Nitto Denko Corporation | Biodegradable polyacetals for in vivo polynucleotide delivery |
| US20080318319A1 (en) * | 2003-12-19 | 2008-12-25 | Yoshiko Minakuchi | Novel Method of Nucleic Acid Transfer |
| HUE025656T2 (en) * | 2004-03-03 | 2016-04-28 | Revance Therapeutics Inc | Topical application and transdermal delivery of botulinum toxins |
| BRPI0508440A (pt) | 2004-03-03 | 2007-07-24 | Revance Therapeutics Inc | composições e métodos para diagnóstico tópico e transporte terapêutico |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| GB0415263D0 (en) * | 2004-07-07 | 2004-08-11 | Norwegian Radium Hospital Res | Method |
| US20060094781A1 (en) * | 2004-11-04 | 2006-05-04 | Syneron Medical Ltd. | Method of treating extracellular matrix |
| FR2877943B1 (fr) * | 2004-11-16 | 2008-09-05 | Univ De Coimbra | Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique |
| ES2362301T3 (es) | 2005-03-03 | 2011-07-01 | Revance Therapeutics, Inc. | Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido. |
| KR20070110402A (ko) | 2005-03-03 | 2007-11-16 | 레반스 테라퓨틱스 | 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법 |
| US7674452B2 (en) * | 2005-03-16 | 2010-03-09 | Nitto Denko Corporation | Polymer coating of cells |
| BRPI0501037B8 (pt) | 2005-03-18 | 2021-07-27 | Fund De Amparo A Pesquisa Do Estado De Sao Paulo | uso de crotamina e composição |
| WO2007059528A2 (en) * | 2005-11-17 | 2007-05-24 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| US7718193B2 (en) * | 2006-03-16 | 2010-05-18 | University Of Washington | Temperature- and pH-responsive polymer compositions |
| GB0613753D0 (en) | 2006-07-11 | 2006-08-23 | Norwegian Radium Hospital Res | Method |
| WO2008073856A2 (en) * | 2006-12-08 | 2008-06-19 | Massachusetts Institute Of Technology | Delivery of nanoparticles and/or agents to cells |
| WO2008082889A2 (en) * | 2006-12-29 | 2008-07-10 | Revance Therapeutics, Inc. | Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat |
| NZ598159A (en) * | 2006-12-29 | 2013-08-30 | Revance Therapeutics Inc | Transport molecules using reverse sequence hiv-tat polypeptides |
| US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
| US7981688B2 (en) | 2007-03-08 | 2011-07-19 | University Of Washington | Stimuli-responsive magnetic nanoparticles and related methods |
| ES2471118T3 (es) | 2007-06-22 | 2014-06-25 | Ekos Corporation | Método y aparato para el tratamiento de hemorragias intracraneales |
| EP2231024A4 (en) * | 2007-12-14 | 2015-03-18 | Ekos Corp | ULTRASOUND PULSE SHAPING |
| GB0811955D0 (en) | 2008-06-30 | 2008-07-30 | Pci Biotech As | Method |
| US8426214B2 (en) * | 2009-06-12 | 2013-04-23 | University Of Washington | System and method for magnetically concentrating and detecting biomarkers |
| GB0914287D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Compositions |
| GB0914286D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Method |
| US20110117668A1 (en) * | 2009-11-09 | 2011-05-19 | University Of Washington Through Its Center For Commercialization | Self-powered smart diagnostic devices |
| US9080933B2 (en) | 2009-11-09 | 2015-07-14 | University Of Washington Through Its Center For Commercialization | Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates |
| GB201208548D0 (en) | 2012-05-15 | 2012-06-27 | Pci Biotech As | Compound and method |
| US20160040128A1 (en) | 2013-03-15 | 2016-02-11 | Pci Biotech As | Method |
| JP6684215B2 (ja) | 2013-08-28 | 2020-04-22 | ピーシーアイ バイオテック エイエス | 予防接種用化合物および免疫化用化合物、ならびに予防接種方法および免疫化方法 |
| GB2517707B (en) * | 2013-08-28 | 2020-09-02 | Pci Biotech As | A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen |
| AU2014390262B2 (en) | 2014-04-11 | 2020-11-26 | Pci Biotech As | Method of treating melanoma |
| WO2016030529A1 (en) | 2014-08-28 | 2016-03-03 | Pci Biotech As | Compound and method |
| GB201503776D0 (en) | 2015-03-05 | 2015-04-22 | Pci Biotech As | Compound and method |
| CN107708581B (zh) | 2015-06-10 | 2021-11-19 | Ekos公司 | 超声波导管 |
| KR20190068573A (ko) | 2016-10-14 | 2019-06-18 | 피씨아이 바이오테크 에이에스 | 젬시타빈의 tpcs-2a 유도된 광화학 내재화로의 담관암의 치료 |
| GB201718631D0 (en) * | 2017-11-10 | 2017-12-27 | Pci Biotech As | Method |
| GB201801169D0 (en) * | 2018-01-24 | 2018-03-07 | Pci Biotech As | Method |
| CA3104833A1 (en) | 2018-07-16 | 2020-01-23 | Dcprime B.V. | A combination product for use in tumor vaccination. |
| US11052144B2 (en) | 2019-04-25 | 2021-07-06 | Dcprime B.V. | Methods of tumor vaccination |
| CN110711249B (zh) * | 2019-09-19 | 2020-10-27 | 北京化工大学 | 一种溶酶体膜包覆纳米颗粒的制备方法 |
| CA3172447A1 (en) | 2020-03-27 | 2021-09-30 | Erik Hans MANTING | In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy |
| US12091681B2 (en) | 2020-03-27 | 2024-09-17 | Mendus B.V. | Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy |
| WO2022003568A1 (en) | 2020-06-30 | 2022-01-06 | Dcprime B.V. | Use of leukemia-derived cells in ovarian cancer vaccines |
| CN114163508B (zh) * | 2020-09-11 | 2024-07-16 | 王月志 | 能破坏细胞的氨基酸序列及相关核苷酸序列和相关的应用 |
| US20220168407A1 (en) | 2020-11-05 | 2022-06-02 | Dcprime B.V. | Use of tumor-independent antigens in immunotherapies |
| KR20230135075A (ko) | 2021-01-22 | 2023-09-22 | 멘두스 비.브이. | 종양 백신접종 방법 |
| GB202101726D0 (en) | 2021-02-08 | 2021-03-24 | Pci Biotech As | Method |
| WO2022190058A1 (en) | 2021-03-12 | 2022-09-15 | Dcprime B.V. | Methods of vaccination and use of cd47 blockade |
| GB202115451D0 (en) | 2021-10-27 | 2021-12-08 | Pci Biotech As | Method |
| IL319617A (en) | 2022-09-27 | 2025-05-01 | Pci Biotech As | Method for releasing viral vectors |
| GB202301312D0 (en) | 2023-01-30 | 2023-03-15 | Pci Biotech As | Method and product |
| GB202404168D0 (en) | 2024-03-22 | 2024-05-08 | Pci Biotech As | Method |
| WO2026159592A1 (en) | 2025-01-21 | 2026-07-30 | Mendus B.V. | Methods for ex vivo expansion of tumor infiltrating lymphocytes |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU563827B2 (en) | 1982-07-01 | 1987-07-23 | Millipore Corp. | Filtration apparatus |
| US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| US4704255A (en) | 1983-07-15 | 1987-11-03 | Pandex Laboratories, Inc. | Assay cartridge |
| US5066274A (en) * | 1985-04-30 | 1991-11-19 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole therapeutic agents |
| US5076950A (en) | 1985-12-20 | 1991-12-31 | Syntex (U.S.A.) Inc. | Magnetic composition for particle separation |
| US4895706A (en) | 1986-10-28 | 1990-01-23 | Costar Corporation | Multi-well filter strip and composite assemblies |
| US5095030A (en) * | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| NO891491D0 (no) * | 1987-08-12 | 1989-04-11 | Peter Nemeth | Prosedyre for befrielse av celleblandinger og vev for uoenskede populasjoner. |
| HU204856B (en) | 1987-08-12 | 1992-02-28 | Orszagos Mueszaki Fejlesztesi | Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates |
| GB8721108D0 (en) * | 1987-09-08 | 1987-10-14 | Salford University Of | Liposomes |
| US5284647A (en) * | 1988-03-18 | 1994-02-08 | Schering Aktiengesellschaft | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them |
| US5256532A (en) | 1988-05-02 | 1993-10-26 | Zynaxis Technologies, Inc. | Methods, reagents and test kits for determination of subpopulations of biological entities |
| US4925736A (en) * | 1988-07-06 | 1990-05-15 | Long Island Jewish Medical Center | Topical hematoporphyrin |
| GB8905001D0 (en) | 1989-03-04 | 1989-04-19 | Univ Leicester | Screening for natural products of microbial metabolism |
| US5567687A (en) * | 1989-03-06 | 1996-10-22 | University Of Texas | Texaphyrins and uses thereof |
| US4935498A (en) * | 1989-03-06 | 1990-06-19 | Board Of Regents, The University Of Texas System | Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles |
| US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| US5059619A (en) * | 1989-06-14 | 1991-10-22 | Quadra Logic Technologies, Inc. | Stable freeze-dried polyhematoporphyrin ether/ester |
| DE3919873A1 (de) | 1989-06-19 | 1990-12-20 | Behringwerke Ag | Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung |
| GB8916859D0 (en) | 1989-07-24 | 1989-09-06 | Dynal As | Hapten linking |
| GB8929297D0 (en) | 1989-12-29 | 1990-02-28 | Dynal As | Method of separation |
| US5200084A (en) | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
| US5491068A (en) | 1991-02-14 | 1996-02-13 | Vicam, L.P. | Assay method for detecting the presence of bacteria |
| US5179120A (en) * | 1991-06-28 | 1993-01-12 | Cytopharm, Inc. | Porphycene compounds for photodynamic therapy |
| PL165249B1 (pl) * | 1991-10-29 | 1994-11-30 | Wojskowa Akad Tech | Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL |
| US5376546A (en) * | 1991-11-04 | 1994-12-27 | Xoma Corporation | Analogs of ribosome-inactivating proteins |
| US5258453A (en) * | 1992-01-21 | 1993-11-02 | University Of Utah | Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light |
| HU217179B (hu) * | 1992-03-16 | 1999-12-28 | Isis Pharmaceuticals Inc. | Oligonukleotidok, oligonukleotidtartalmú készítmények és eljárások protein kináz C expressziójának modulálására |
| DK0631634T3 (da) | 1992-03-20 | 1996-06-24 | Celsis Int Plc | Fremgangsmåde og apparat til analyse af biologisk materiale |
| AU4115693A (en) * | 1992-04-24 | 1993-11-29 | Sri International | In vivo homologous sequence targeting in eukaryotic cells |
| WO1994007138A1 (en) | 1992-09-14 | 1994-03-31 | Fodstad Oystein | Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |
| US5985620A (en) * | 1992-11-03 | 1999-11-16 | Gene Shears Pty. Limited | TNF-α Ribozymes |
| FR2700010B1 (fr) | 1992-12-24 | 1995-03-17 | Rocher Yves Biolog Vegetale | Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits. |
| US5374531A (en) | 1993-03-22 | 1994-12-20 | Zynaxis, Inc. | Immunoassay for determination of cells |
| US5861310A (en) * | 1993-11-03 | 1999-01-19 | Dana-Farber Cancer Institute | Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
| US5491084A (en) * | 1993-09-10 | 1996-02-13 | The Trustees Of Columbia University In The City Of New York | Uses of green-fluorescent protein |
| US6015897A (en) * | 1993-12-07 | 2000-01-18 | Neorx Corporation | Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota |
| US5514340A (en) | 1994-01-24 | 1996-05-07 | Magnetix Biotechnology, Inc. | Device for separating magnetically labelled cells |
| NO180658C (no) | 1994-03-10 | 1997-05-21 | Oeystein Fodstad | Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner |
| NO180167C (no) | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US5872007A (en) * | 1995-02-17 | 1999-02-16 | Hybridon, Inc. | CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer |
-
1994
- 1994-09-08 NO NO943327A patent/NO180167C/no not_active IP Right Cessation
-
1995
- 1995-09-04 US US08/793,794 patent/US5876989A/en not_active Expired - Lifetime
- 1995-09-04 AU AU35347/95A patent/AU700797B2/en not_active Expired
- 1995-09-04 NZ NZ509519A patent/NZ509519A/en not_active IP Right Cessation
- 1995-09-04 HU HU9800153A patent/HU222984B1/hu active IP Right Grant
- 1995-09-04 WO PCT/NO1995/000149 patent/WO1996007432A1/en not_active Ceased
- 1995-09-04 EP EP95932244A patent/EP0783323B1/en not_active Expired - Lifetime
- 1995-09-04 BR BRPI9508825A patent/BRPI9508825B8/pt not_active IP Right Cessation
- 1995-09-04 MX MX9701676A patent/MX9701676A/es unknown
- 1995-09-04 DE DE69524238T patent/DE69524238T2/de not_active Expired - Lifetime
- 1995-09-04 NZ NZ293008A patent/NZ293008A/en not_active IP Right Cessation
- 1995-09-04 ES ES95932244T patent/ES2163527T3/es not_active Expired - Lifetime
- 1995-09-04 PT PT95932244T patent/PT783323E/pt unknown
- 1995-09-04 JP JP50940496A patent/JP4148328B2/ja not_active Expired - Fee Related
- 1995-09-04 CZ CZ97658A patent/CZ65897A3/cs unknown
- 1995-09-04 AT AT95932244T patent/ATE209507T1/de active
- 1995-09-04 CN CNB951960652A patent/CN1222309C/zh not_active Expired - Lifetime
- 1995-09-04 CA CA2199290A patent/CA2199290C/en not_active Expired - Lifetime
- 1995-09-14 KR KR10-2003-7005142A patent/KR100529967B1/ko not_active Expired - Fee Related
- 1995-09-14 KR KR1019970701520A patent/KR100395615B1/ko not_active Expired - Lifetime
-
1997
- 1997-03-07 FI FI970983A patent/FI121328B/fi not_active IP Right Cessation
-
1998
- 1998-09-01 US US09/144,750 patent/US6680301B2/en not_active Expired - Fee Related
-
2002
- 2002-11-01 US US10/286,632 patent/US20030134813A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943327L (no) | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol | |
| MXPA03002413A (es) | Moleculas tipo b7 y uso de las mismas. | |
| BR0210839A (pt) | Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico | |
| EP0883344A4 (en) | THERAPEUTIC MOLECULES OBTAINED BY TRANS-SPLITTING | |
| WO2002036743A3 (en) | Antisense modulation of calreticulin expression | |
| AU5753598A (en) | Novel genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use | |
| CA2394984A1 (en) | Novel plant expression constructs | |
| DK0923592T3 (da) | Fremgangsmåder til rensning af nukleinsyrer | |
| EP2199299A3 (en) | Antisense modulation of survivin expression | |
| WO2003011887A3 (en) | Antisense modulation of apolipoprotein b expression | |
| WO2003014307A3 (en) | Antisense modulation of apolipoprotein(a) expression | |
| TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
| DK1681355T3 (da) | Sekvensspecifik DNA-rekombination i eukaryote celler | |
| AR023482A1 (es) | Acidos nucleicos que codifican polipeptidos quimericos cd40/cd4ol, metodos para su produccion y usos de los mismos | |
| WO2001029175A3 (en) | Antisense modulation of fra-1 expression | |
| AU2672099A (en) | Compositions and methods for wound healing | |
| ATE402257T1 (de) | Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit | |
| WO2002050248A3 (en) | Antisense modulation of hepsin expression | |
| WO2002050244A3 (en) | Antisense modulation of histone deacetylase 1 expression | |
| GEP19991780B (en) | Use of Pyrrolidine Derivatives for Treating Alcoholism | |
| WO2003050247A3 (en) | Antisense modulation of mhc class ii transactivator expression | |
| IL131436A0 (en) | Compositions for treatment of disorders involving programmed cell death | |
| BR0010396A (pt) | Composições e métodos para a modificação da expressão de genes | |
| WO2003040161A3 (en) | Antisense modulation of activating transcription factor 3 expression | |
| DE69733948D1 (de) | In vivo herstellung von replicativen molekülen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |